A detailed history of Cullen Investment Group, Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 68,366 shares of JNJ stock, worth $10.5 Million. This represents 1.65% of its overall portfolio holdings.

Number of Shares
68,366
Previous 67,961 0.6%
Holding current value
$10.5 Million
Previous $9.93 Billion 11.54%
% of portfolio
1.65%
Previous 1.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$145.48 - $167.38 $58,919 - $67,788
405 Added 0.6%
68,366 $11.1 Billion
Q2 2024

Jul 01, 2024

SELL
$144.38 - $157.78 $90,093 - $98,454
-624 Reduced 0.91%
67,961 $9.93 Billion
Q1 2024

Apr 04, 2024

BUY
$155.22 - $162.74 $278,309 - $291,792
1,793 Added 2.68%
68,585 $10.8 Billion
Q4 2023

Jan 30, 2024

BUY
$145.6 - $158.88 $9.72 Million - $10.6 Million
66,792 New
66,792 $10.5 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cullen Investment Group, Ltd. Portfolio

Follow Cullen Investment Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Investment Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Cullen Investment Group, Ltd. with notifications on news.